Sign in

CIK 0000907654

  • Non-accelerated filer
  • Smaller reporting company

Oruka Therapeutics, Inc.

Sign in to watch
Ticker
ORKA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363855489
Phone
+1 650-606-7910
Business address
855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
Former names
ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale Chief Operating Officer sold 483 shares at $2.45 ($1,184)
  11. 4 Open-market sale Pres. & Chief Executive Offic sold 1,972 shares at $2.89 ($5,699)
  12. 4 Open-market sale Chief Operating Officer sold 714 shares at $2.89 ($2,063)
  13. 4 Open-market sale S.V.P., General Counsel sold 1,185 shares at $2.89 ($3,425)
  14. 4 Open-market sale VP, Finance sold 476 shares at $2.91 ($1,385)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale BRISTOW MICHAEL R sold 724 shares at $3.52 ($2,548)
  20. 4 Open-market sale S.V.P., General Counsel sold 366 shares at $3.52 ($1,288)

Page 10 of 23 · 459 filings